Capitolis Liquid Global Markets’s Bristol-Myers Squibb BMY Stock Holding History

Capitolis Liquid Global Markets’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.07M	Sell	100,000 -179,710	-64%	-$10.5M	0.04%	234
2025 Q4	$15.1M	Buy	279,710 +73,710	+36%	+$3.55M	0.09%	129
2025 Q3	$9.29M	Sell	206,000 -733,200	-78%	-$34.2M	0.07%	143
2025 Q2	$43.5M	Buy	+939,200	New	+$46.1M	0.32%	60
2024 Q1	–	Sell	-869,500	Closed	-$44.6M	–	120
2023 Q4	$44.6M	Buy	+869,500	New	+$45.6M	1.83%	18

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capitolis Liquid Global Markets's BMY Position: Q1 2026 in Review

Capitolis Liquid Global Markets reduced its Bristol-Myers Squibb (BMY) stake by 64% in Q1 2026, selling an estimated $10.5M and leaving 100,000 shares worth $6.07M. The position accounts for 0.04% of the portfolio, ranked #234.

Capitolis Liquid Global Markets first reported a position in BMY in Q4 2023 and has held it in 5 quarters since. The position peaked at $44.6M in Q4 2023. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Capitolis Liquid Global Markets held 100,000 shares of Bristol-Myers Squibb worth $6.07M as of Q1 2026.
Capitolis Liquid Global Markets sold 179,710 Bristol-Myers Squibb shares in Q1 2026, an estimated $10.5M.
Bristol-Myers Squibb made up 0.04% of Capitolis Liquid Global Markets's portfolio in Q1 2026, its #234 holding.
Capitolis Liquid Global Markets first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 5 quarters since.
Capitolis Liquid Global Markets's Bristol-Myers Squibb position peaked at $44.6M in Q4 2023.
2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Capitolis Liquid Global Markets's 13F filing for Q1 2026, filed 15 May 2026.